Prelude Capital Management, LLC Applied Genetic Technologies Corp Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.36 - $9.86 $346 - $1,449	-147 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.69 - $4.92 $40 - $73	-15 Reduced 9.26%	147 $1,000
Q3 2019 Nov 14, 2019	BUY	$2.59 - $4.16 $419 - $673	162 New	162 $1,000
Q4 2017 Feb 14, 2018	SELL	$3.4 - $4.15 $54,060 - $65,985	-15,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $56,445 - $83,475	15,900	15,900 $63,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.